Ophthalmologists Implant First Visian Toric ICLs in the US
STAAR Surgical Company (STAA)
Last staar surgical company earnings: 2/26 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=71327&p=irol-irhome
Company Research
Source: Business Wire
Toric Implantable Collamer Lens Provides Vision Correction for Patients with Myopia and Astigmatism MONROVIA, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the first patient implants of the company’s Visian Toric Implantable Collamer Lenses (TICLs) in the U.S. by Brinton Vision in St. Louis, Missouri, and Parkhurst NuVision in San Antonio, Texas. A select group of leading surgeons around the country began implanting TICLs soon thereafter, including Dr. Paul Dougherty in Los Angeles and Dr. Scott Perkins in Phoenix. The TICL was approved in the U.S. by the FDA on September 13, 2018, and the first patient implants occurred on October 22, 2018. The Visian TICL has been approved and available for patients outside of the U.S. since 2002. “The Visian Toric
Show less
Read more
Impact Snapshot
Event Time:
STAA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STAA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STAA alerts
High impacting STAAR Surgical Company news events
Weekly update
A roundup of the hottest topics
STAA
News
- STAAR Surgical (NASDAQ: STAA) had its price target raised by analysts at Mizuho from $45.00 to $53.00. They now have a "buy" rating on the stock.MarketBeat
- STAAR Surgical (NASDAQ: STAA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $32.00 to $46.00. They now have a "hold" rating on the stock.MarketBeat
- STAAR Surgical (NASDAQ: STAA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.MarketBeat
- Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength? [Yahoo! Finance]Yahoo! Finance
- STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge [Seeking Alpha]Seeking Alpha
STAA
Earnings
- 2/26/24 - Beat
STAA
Sec Filings
- 4/4/24 - Form 8-K
- 3/18/24 - Form 8-K
- 3/14/24 - Form 4
- STAA's page on the SEC website